E-LIB Suche - Ergebnisse für: Bader, Justin

1

Safety and pharmacokinetics of SPR206 in subjects with vary..:

Bruss, Jon B. ; Bader, Justin ; Hamed, Kamal A..
Antimicrobial Agents and Chemotherapy. 67 (2023) 11 - p. , 2023

Link: https://doi.org/10.1128/..

2

Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial ..:

Rodvold, Keith A. ; Bader, Justin ; Bruss, Jon B..
Antimicrobial Agents and Chemotherapy. 67 (2023) 7 - p. , 2023

Link: https://doi.org/10.1128/..

3

625. SPR206 Pharmacokinetics (PK) in Plasma, Epithelial Lin..:

Rodvold, Keith A ; Bader, Justin ; Gupta, Vipul K...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

4

1695. Combination Therapy for the Investigational Polymyxin..:

Louie, Arnold ; Bader, Justin ; Cotroneo, Nicole...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

5

A phase 1 clinical trial of oral eltanexor in patients with..:

Cornell, Robert Frank ; Baz, Rachid ; Richter, Joshua R....
American Journal of Hematology. 97 (2021) 2 - p. , 2021

Link: https://doi.org/10.1002/..

6

Use of ceftaroline after glycopeptide failure to eradicate ..:

Paladino, Joseph A. ; Jacobs, David M. ; Shields, Ryan K....
International Journal of Antimicrobial Agents. 44 (2014) 6 - p. 557-563 , 2014

Link: https://doi.org/10.1016/..

7

2130. Safety and Pharmacokinetics of SPR206 in Subjects wit..:

Bruss, Jon ; Bader, Justin C ; Hamed, Kamal
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

8

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses ..:

Bhavnani, Sujata M. ; Hammel, Jeffrey P. ; Lakota, Elizabeth A....
Antimicrobial Agents and Chemotherapy. 67 (2023) 4 - p. , 2023

Link: https://doi.org/10.1128/..

9

Resident and circulating memory T cells persist for years i..:

Han, Jichang ; Zhao, Yanding ; Shirai, Keisuke...
Nature Cancer. 2 (2021) 3 - p. 300-311 , 2021

Link: https://doi.org/10.1038/..

10

Selinexor population pharmacokinetic and exposure–response ..:

Xu, Hongmei ; Li, Hanbin ; Wada, Russ...
Cancer Chemotherapy and Pharmacology. 88 (2021) 1 - p. 69-79 , 2021

Link: https://doi.org/10.1007/..

11

Pharmacokinetics of Selinexor: The First-in-Class Selective..:

Bader, Justin C. ; Abdul Razak, Albiruni R. ; Shacham, Sharon.
Clinical Pharmacokinetics. , 2021

Link: https://doi.org/10.1007/..

12

Pharmacokinetic/pharmacodynamic target attainment analyses ..:

Bhavnani, Sujata M ; Zhang, Li ; Hammel, Jeffrey P...
Journal of Antimicrobial Chemotherapy. 74 (2019) Supplement_3 - p. iii35-iii41 , 2019

Link: https://doi.org/10.1093/..

13

1389. Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of..:

Lepak, Alexander J ; Zhao, Miao ; Liu, Qingmei...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S426-S426 , 2018

Link: https://doi.org/10.1093/..

14

Correction to: PK–PD Compass: bringing infectious diseases ..:

Bulik, Catharine C. ; Bader, Justin C. ; Zhang, Li...
Journal of Pharmacokinetics and Pharmacodynamics. 45 (2018) 2 - p. 351-351 , 2018

Link: https://doi.org/10.1007/..

15

We can do better: a fresh look at echinocandin dosing:

Bader, Justin C ; Bhavnani, Sujata M ; Andes, David R.
Journal of Antimicrobial Chemotherapy. 73 (2018) suppl_1 - p. i44-i50 , 2018

Link: https://doi.org/10.1093/..